Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancer.
Saved in:
| Title: | Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancer. |
|---|---|
| Authors: | Ly E; Department of Pharmacy, University of Chicago Medicine, Chicago, IL, USA., Howard FM; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Chen N; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Hahn O; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Fleming GF; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Nanda R; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Patel S; Department of Pharmacy, University of Chicago Medicine, Chicago, IL, USA., Thimothy L; Department of Pharmacy, University of Chicago Medicine, Chicago, IL, USA., Yang H; Department of Pharmacy, University of Chicago Medicine, Chicago, IL, USA. |
| Source: | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2026 Jun; Vol. 32 (4), pp. 641-647. Date of Electronic Publication: 2024 Dec 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-092X |
|---|---|
| DOI: | 10.1177/10781552241305417 |
